Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN81,0281,1-0,74
Msft1,86
Nokia3,9784,03-0,22
IBM0,53
Mercedes-Benz Group AG51,4351,45-0,16
PFE-0,50
20.09.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 19.09.2025
CNO Finan (CNO, NY Consolidated)
Závěr k 19.9.2025 Změna (%) Změna (USD) Objem obchodů (ks)
39,60 0,05 0,02 3 887 737
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: CNO Financial Group, Inc. is a holding company for a group of insurance companies. It provides life and health insurance, annuities, financial services and workforce benefits solutions through its family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. It is focused on serving middle-income pre-retiree and retired Americans. It markets its products through the Consumer and Worksite Divisions that reflect the customers served by the Company. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on the sale of voluntary benefit life and health insurance products in the workplace for businesses, associations and other membership groups, interacting with customers at their place of employment and virtually. It also offers a suite of voluntary benefits, benefits administration technology and advocacy services.
Financial Summary: BRIEF: For the six months ended 30 June 2025, CNO Financial Group Inc revenues decreased 3% to $2.18B. Net income decreased 54% to $105.5M. Revenues reflect Unallocated segment decrease of 28% to $335.1M. Net income also reflects FV Adjustments of Financial Investments decrease from $13.9M (income) to $4.4M (expense), Other operating costs and expenses increase of 3% to $546.4M (expense). Dividend per share increased from $0.31 to $0.33.



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerPhillip Frost8827.03.200727.03.2007
President, Vice Chairman of the BoardElias Zerhouni7309.05.202209.05.2022
Vice Chairman of the Board, Chief Technical OfficerJane Hsiao7704.05.200704.05.2007
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, TreasurerAdam Logal4627.03.2007
Chief Executive Officer of OPKO RenalCharles Bishop73
Chief Executive Officer, Transition Therapeutics, IncTony Cruz71
Executive Vice President - Administration, DirectorSteven Rubin6404.05.200704.05.2007
Chief Innovation Officer, DirectorGary Nabel7109.05.202209.05.2022